Jun 04, 2020
Evolugate Takes Up the Challenge of Boosting Host Cells Used to Manufacture COVID-19 Vaccines
Jun 04, 2020
Intravacc Partners With Wageningen Bioveterinary Research and Utrecht University to Develop an Intranasal COVID-19 Vaccine
Jun 04, 2020
INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea
Jun 03, 2020
Developing a COVID-19 Vaccine Quickly Proving to be a Daunting Task But Progress Still Expected
Jun 03, 2020
Novavax Selects AGC Biologics to Manufacture Matrix-M(TM) Adjuvant for Novel COVID-19 Vaccine
Jun 02, 2020
Intravacc and EpiVax Team up in Development of COVID-19 Emerging Vaccine
May 29, 2020
Global Vaccines market is Expected to Reach $81.27 Billion by 2027 - Latest Market Research Report by Stratistics MRC
May 20, 2020
INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models
May 12, 2020
NEOVII to Develop a Novel Vaccine for COVID-19 in an Exclusive Partnership With Tel Aviv University
May 11, 2020
INOVIO Reports First Quarter 2020 Financial Results; Provides Business Update
May 05, 2020
NYU Langone Among First Centers to Enroll Patients in US Clinical Trial for COVID-19 mRNA Vaccine
May 04, 2020
BiondVax Announces Upcoming Expiration of Public Warrants
Apr 28, 2020
INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June
Apr 28, 2020
COVID-19 Crisis Focuses Attention on Oft-Overlooked Vaccine Industry
Apr 28, 2020
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference
Apr 28, 2020
The Global Travel Vaccines Market is expected to grow from USD 4,783.03 Million in 2018 to USD 8,937.49 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.34%
Apr 24, 2020
Hoth Therapeutics, Inc., Voltron Therapeutics, Inc., & HaloVax Announce Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 Vaccine
Apr 23, 2020
Johnson & Johnson Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine Candidate in Support of the Company's Goal to Supply More Than One Billion Vaccine Doses Globally
Apr 23, 2020
Prime Minister announces new support for COVID-19 medical research and vaccine development
Apr 23, 2020
ReiThera, LEUKOCARE and Univercells Announce Pan-European Consortium for the Fast-track Development of a Single-dose Adenovirus-based COVID-19 Vaccine